| Systemic Sclerosis and Related Diseases | Lifetime | 10 | CA 1 | 99.77 |
| Dermatologic Treatments and Research | Lifetime | 21 | CA 1 | 99.61 |
| Systemic Lupus Erythematosus Research | Lifetime | 65 | CA 2 | 99.66 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 62 | CA 5 | 99.69 |
| Skin Diseases and Diabetes | Lifetime | 11 | CA 1 | 99.20 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 75 | CA 4 | 99.41 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 51 | CA 4 | 99.50 |
| Mast cells and histamine | Lifetime | 43 | CA 2 | 99.14 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 47 | CA 3 | 99.16 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 379 | CA 12 | 98.91 |
| Dermatological and Skeletal Disorders | Lifetime | 60 | CA 2 | 98.39 |
| Connective Tissue Growth Factor Research | Lifetime | 30 | CA 3 | 98.03 |
| Biosimilars and Bioanalytical Methods | Lifetime | 141 | CA 11 | 97.11 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 306 | CA 11 | 97.78 |
| Autoimmune Bullous Skin Diseases | Lifetime | 283 | CA 11 | 97.87 |
| Lymphoma Diagnosis and Treatment | Lifetime | 956 | CA 28 | 97.86 |
| Spondyloarthritis Studies and Treatments | Lifetime | 232 | CA 12 | 97.65 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 732 | CA 33 | 96.78 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 396 | CA 25 | 95.13 |
| Eosinophilic Disorders and Syndromes | Lifetime | 686 | CA 13 | 95.37 |
| Peripheral Neuropathies and Disorders | Lifetime | 627 | CA 21 | 95.63 |
| Vasculitis and related conditions | Lifetime | 635 | CA 19 | 94.69 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 676 | CA 37 | 85.59 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 35 | CA 3 | 98.21 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 90 | CA 2 | 98.28 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 252 | CA 12 | 95.50 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 313 | CA 13 | 95.66 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 502 | CA 13 | 95.06 |
| Mast cells and histamine | 2021-2025 | 74 | CA 1 | 94.06 |
| Dermatologic Treatments and Research | 2021-2025 | 207 | CA 4 | 91.42 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 241 | CA 9 | 88.75 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 412 | CA 18 | 91.13 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 325 | CA 13 | 85.70 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 791 | CA 12 | 78.62 |
| Vasculitis and related conditions | 2021-2025 | 822 | CA 19 | 78.70 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 908 | CA 30 | 77.30 |
| Dermatological and Skeletal Disorders | 2021-2025 | 274 | CA 4 | 67.04 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 560 | CA 13 | 62.47 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 945 | CA 40 | 38.11 |
| Connective Tissue Growth Factor Research | 2021-2025 | 299 | CA 7 | 25.48 |
